In addition, YAP/TAZ are activated in multiple human tumors including BC, hepatocellular carcinoma (HCC), prostate cancer, and lung cancer,68, 69, 70, 71 which is considered to be indicative of poor prognosis. This evidence concerns the gene YAP1 and breast cancer.